Squarepoint’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-153,841
Closed -$12.3M 2201
2016
Q4
$12.3M Buy
153,841
+63,343
+70% +$5.03M 0.5% 28
2016
Q3
$7.22M Buy
90,498
+12,675
+16% +$1.02M 0.48% 34
2016
Q2
$6.07M Sell
77,823
-10,704
-12% -$763K 0.38% 37
2016
Q1
$4.87M Buy
88,527
+70,171
+382% +$3.82M 0.38% 41
2015
Q4
$1.13M Buy
18,356
+9,214
+101% +$581K 0.12% 234
2015
Q3
$577K Buy
9,142
+4,944
+118% +$353K 0.14% 177
2015
Q2
$307K Sell
4,198
-22,635
-84% -$1.64M 0.1% 290
2015
Q1
$1.75M Buy
+26,833
New +$1.78M 0.61% 30

Other funds holding STJ

Squarepoint's STJ Position: Q1 2017 in Review

Squarepoint sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 153,841 shares — an estimated $12.3M sold.

Squarepoint first reported a position in STJ in Q1 2015 and held it in 8 quarters. The position peaked at $12.3M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Squarepoint reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Squarepoint sold 153,841 St Jude Medical shares in Q1 2017, an estimated $12.3M.
  • Squarepoint first reported a position in St Jude Medical in Q1 2015 and held it in 8 quarters.
  • Squarepoint's St Jude Medical position peaked at $12.3M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Squarepoint's 13F filing for Q1 2017, filed 15 May 2017.